학술논문
PRECLINICAL DISCOVERY AND DEVELOPMENT OF MEDI1814, A MONOCLONAL ANTIBODY SELECTIVELY TARGETING BETA-AMYLOID 42 (Aβ42)
Document Type
Abstract
Author
Source
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2017 13(7) Supplement:P266-P266
Subject
Language
ISSN
1552-5260